Menu
GeneBe

OXT

oxytocin/neurophysin I prepropeptide, the group of Neuropeptides

Basic information

Region (hg38): 20:3071619-3072517

Previous symbols: [ "OT" ]

Links

ENSG00000101405NCBI:5020OMIM:167050HGNC:8528Uniprot:P01178AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OXT gene.

  • Inborn genetic diseases (3 variants)
  • not provided (1 variants)
  • Neurodevelopmental disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OXT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
3
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 4 0 0

Variants in OXT

This is a list of pathogenic ClinVar variants found in the OXT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-3071650-C-CGCACCATGGCCG Neurodevelopmental disorder Uncertain significance (Jan 01, 2019)982583
20-3071681-G-T not specified Uncertain significance (Jul 20, 2021)3207602
20-3072099-G-A not specified Uncertain significance (Mar 16, 2022)2225372
20-3072246-G-A not specified Uncertain significance (Jan 26, 2022)2273580
20-3072358-T-C Benign (Dec 31, 2019)769991
20-3072363-A-G not specified Uncertain significance (Oct 27, 2022)2321158
20-3072364-C-G not specified Uncertain significance (Dec 27, 2023)3207603

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OXTprotein_codingprotein_codingENST00000217386 3898
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7120.27500000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7875472.90.7410.00000359775
Missense in Polyphen1528.8880.51925334
Synonymous1.282433.40.7190.00000180250
Loss of Function1.8804.100.001.74e-752

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Neurophysin 1 specifically binds oxytocin.;
Pathway
Oxytocin signaling pathway - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Vasopressin-like receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.345

Haploinsufficiency Scores

pHI
0.0892
hipred
Y
hipred_score
0.547
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.724

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowLow
Primary ImmunodeficiencyMediumLowMedium
CancerMediumLowMedium

Mouse Genome Informatics

Gene name
Oxt
Phenotype
endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;

Zebrafish Information Network

Gene name
oxt
Affected structure
vH ionocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
response to amphetamine;regulation of heart rate;maternal aggressive behavior;signal transduction;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;heart development;female pregnancy;memory;grooming behavior;response to sucrose;regulation of signaling receptor activity;positive regulation of norepinephrine secretion;response to activity;sleep;response to food;positive regulation of prostaglandin secretion;response to estradiol;response to retinoic acid;response to progesterone;response to prostaglandin E;social behavior;negative regulation of urine volume;positive regulation of renal sodium excretion;response to cocaine;hyperosmotic salinity response;maternal behavior;sperm ejaculation;eating behavior;drinking behavior;response to peptide hormone;response to ether;negative regulation of blood pressure;positive regulation of blood pressure;positive regulation of ossification;positive regulation of female receptivity;positive regulation of synaptic transmission;response to glucocorticoid;response to cAMP;response to electrical stimulus;regulation of sensory perception of pain;positive regulation of synapse assembly;male mating behavior;positive regulation of penile erection;positive regulation of hindgut contraction;negative regulation of gastric acid secretion;positive regulation of uterine smooth muscle contraction;positive regulation of cold-induced thermogenesis
Cellular component
extracellular region;extracellular space;secretory granule;terminal bouton
Molecular function
neurohypophyseal hormone activity;oxytocin receptor binding